AGM/EGMApr 30, 2026, 04:48 PM
SABS to Hold 2026 Annual Meeting on June 18; Elect Directors, Ratify Auditor
AI Summary
SAB Biotherapeutics, Inc. announced its 2026 Virtual Annual Meeting of Stockholders will be held on June 18, 2026, at 10:00 AM ET. Stockholders of record as of April 20, 2026, are invited to vote on two key proposals: the election of four Class II directors and the ratification of EisnerAmper LLP as the independent auditor for fiscal year 2026. The Board recommends voting "FOR" both proposals.
Key Highlights
- Annual Meeting scheduled for Thursday, June 18, 2026, at 10:00 AM ET, virtually.
- Record date for voting eligibility is April 20, 2026.
- Proposals include electing four Class II directors: Dr. David Zaccardelli, Katie Ellias, David Link, and Andrew Moin.
- Proposal to ratify EisnerAmper LLP as independent auditor for fiscal year ending December 31, 2026.
- Board recommends voting "FOR" all director nominees and "FOR" auditor ratification.
- 50,951,037 shares of common stock outstanding and 28,380 shares of Series A Preferred Stock outstanding as of record date.
- Series A Preferred Stock holders are not entitled to vote at this meeting due to beneficial ownership limitation.
- Stockholders can vote by mail, telephone, Internet, or virtually at the meeting.
Price Impact
More from SABS